TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biotech Fluidics AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
95,731
|
68,631
|
58,205 |
Financial expenses |
1
|
4
|
12 |
Earnings before taxes |
13,845
|
9,993
|
4,308 |
EBITDA |
12,885
|
6,700
|
3,613 |
Total assets |
43,419
|
29,152
|
20,661 |
Current assets |
38,903
|
24,462
|
16,176 |
Current liabilities |
14,873
|
8,761
|
6,150 |
Equity capital |
27,064
|
19,077
|
13,537 |
- share capital |
96
|
98
|
105 |
Employees (average) |
13
|
12
![]() |
12 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
62.3%
|
65.4%
|
65.5% |
Turnover per employee |
7,364
|
5,719
|
4,850 |
Profit as a percentage of turnover |
14.5%
|
14.6%
|
7.4% |
Return on assets (ROA) |
31.9%
|
34.3%
|
20.9% |
Current ratio |
261.6%
|
279.2%
|
263.0% |
Return on equity (ROE) |
51.2%
|
52.4%
|
31.8% |
Change turnover |
29,162
|
14,448
|
4,299 |
Change turnover % |
44%
|
27%
|
8% |
Chg. No. of employees |
1
|
0
|
2 |
Chg. No. of employees % |
8%
|
0%
|
20% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.